Global Advanced Visualization Market Outlook, 2031

Advanced visualization is the software and hardware used to turn medical imaging data into three-dimensional and four-dimensional views, quantitative measurements and interactive models that go beyond the standard two-dimensional slices seen in a PACS viewer. Typical functions include multiplanar reformatting, volume rendering, maximum intensity projection, segmentation of organs, vessels and tumours, centreline and stenosis analysis, perfusion and flow analysis, image fusion between modalities, virtual endoscopy and colonography, and planning tools for surgery, intervention and radiotherapy. The tools are used with computed tomography, magnetic resonance, positron emission tomography, ultrasound, angiography and microscopy data. Suppliers include scanner makers whose platforms are bundled with their equipment, such as GE HealthCare with AW, Philips with IntelliSpace Portal and Siemens Healthineers with syngo.via, as well as software specialists such as Canon Medical Informatics with Vitrea, Fujifilm with Synapse 3D, TeraRecon, Visage Imaging, Materialise, Brainlab, Circle Cardiovascular Imaging and Ziosoft. A growing group of AI-based companies, including HeartFlow, Cleerly and Elucid, provide cardiovascular analysis that can be reimbursed as a service. Software is typically licensed per server, per user or per study and may run on a thin client, with heavy rendering performed on servers or in the cloud. Customers include hospitals, imaging centres, surgical teams and research institutes.

The market now sits at an inflection point shaped by artificial intelligence, cloud delivery and the spread of immersive and three-dimensional tools in the operating room. AI-assisted segmentation and quantification are moving from research to routine use, with coronary plaque analysis, fractional flow reserve derived from CT, lung nodule tracking, liver and kidney volumetry and prostate and brain tumour measurement now available from multiple vendors. Cloud and web-based platforms are replacing heavy workstations, and the line between PACS viewers and advanced visualization is blurring as vendors add 3D tools to standard viewers. Surgeons and interventionalists are exploring augmented and mixed reality, patient-specific 3D printed models and digital twins, although headset hardware has changed rapidly, with Microsoft ending HoloLens 2 production and Apple launching Vision Pro. Reimbursement codes and clinical guidelines are starting to recognise some advanced analyses. For researchers, the key variables through 2031 are the pace of AI adoption and its reimbursement, the shift from workstation to cloud, vendor consolidation, regulatory clearance routes, the use of immersive devices in procedures, and demand for patient-specific planning in cardiology, oncology and orthopaedics.

Drivers •Growth of Complex Imaging and Image-Guided Procedures: Cardiac CT, MR, PET and hybrid imaging produce rich datasets that need dedicated tools to extract diagnostic value, and minimally invasive procedures such as transcatheter valve replacement, structural heart interventions, tumour ablation and spine surgery rely on detailed 3D planning. Hospitals invest in advanced visualization to improve diagnostic confidence, reduce procedure time and plan complex operations, and multidisciplinary tumour boards depend on shared 3D views. As more procedures move to image guidance, demand for planning and navigation software rises through 2031.

•Artificial Intelligence and Reimbursement for Quantitative Analysis: AI automates time-consuming steps such as segmentation and measurement, which saves radiologist and technologist time and improves consistency. Reimbursement is emerging for specific analyses, with a Category I CPT code for CT-derived fractional flow reserve effective from January 2024 in the United States, and payers evaluating coverage for plaque analysis. When an analysis is reimbursed, hospitals have a financial reason to adopt it, which supports growth of subscription and per-case offerings from specialist vendors and gives scanner makers an incentive to partner with them.

Challenges •Workflow Fit, Cost and Evidence Requirements: Advanced tools must fit into busy reading workflows, and clinicians are reluctant to adopt software that requires extra steps or separate logins. Licences, servers and integration add cost, and smaller hospitals may find it hard to justify specialist products without clear reimbursement. Outcome evidence is still limited for many tools, and payers want proof of clinical benefit before covering new analyses. Differences between vendors' algorithms and a lack of standard measurement protocols can reduce confidence, so large trials and guidelines are needed to widen acceptance.



•Regulatory Complexity and Hardware Volatility: Many advanced visualization and AI products are regulated as medical devices and need clearance or approval in each major market, and updates to algorithms raise questions about change control and post-market monitoring. Immersive hardware has been unstable, with Microsoft discontinuing HoloLens 2 production in 2024 and newer headsets still costly and heavy for long procedures, which complicates product roadmaps for mixed-reality surgical applications. Cybersecurity, data privacy and the need to validate cloud processing add further burden for vendors and hospitals.

Trends •Cloud Rendering and Web-Based Advanced Tools: Vendors are delivering 3D and quantitative tools through browser-based viewers where heavy processing runs on cloud servers or GPU clusters, so users can work from any workstation without installing software. Visage 7, Sectra, Philips, GE HealthCare and others are adding advanced tools directly to enterprise viewers, which lets radiologists use 3D functions without leaving the PACS. Open frameworks such as MONAI and cloud AI services from NVIDIA and the large cloud providers lower the cost of developing new algorithms. This approach supports multi-site access and lower maintenance, though bandwidth and data sovereignty remain concerns.

•Patient-Specific Planning, 3D Printing and Immersive Tools: Hospitals are building point-of-care 3D printing and planning labs that use software from Materialise, Stratasys partners and others to create models and surgical guides from CT and MR data. Mixed reality and virtual reality tools let surgeons rehearse operations, overlay anatomy during procedures and teach residents, with applications on devices from Apple, Meta, Magic Leap and others. Digital twins of the heart, vessels and tumours, combined with flow and stress simulation, are being studied for planning and device selection. Clinical evidence and cost remain constraints, but momentum is strong in orthopaedics, neurosurgery, cardiology and congenital heart disease.

CT-based visualization leads because CT is the most widely used modality for 3D reconstruction and cardiovascular, oncology and trauma applications, while MRI, ultrasound and molecular imaging provide growing demand for fusion, quantification and perfusion analysis. CT advanced visualization supports vascular analysis, coronary imaging, virtual colonoscopy, lung and liver assessment and trauma reconstruction, and photon-counting CT is increasing detail and data volume. MRI visualization includes neuro tractography, cardiac function, perfusion, and prostate and breast analysis, and relies on larger datasets with multiple sequences. Ultrasound 3D and 4D imaging is used in obstetrics and cardiology, with automated measurements and fusion with CT for guidance. PET and SPECT visualization uses fusion with CT and MR for oncology, neurology and cardiology, and quantification of uptake. X-ray angiography and fluoroscopy provide 3D rotational reconstruction for interventional planning. Other sources include microscopy and optical coherence tomography. Through 2031, multi-modality fusion and AI-assisted measurement are expected to be the main areas of product development.


Cardiology leads by application because cardiac CT, MR and interventional planning depend heavily on 3D tools and quantification, while oncology and neurology are large segments and orthopaedic and surgical planning is the fastest-growing niche. Cardiology applications include coronary CT angiography analysis, calcium scoring, plaque quantification, CT-derived fractional flow reserve, structural heart planning for valve replacement and left atrial appendage closure, and cardiac MR. Oncology uses tools for tumour segmentation, response assessment, radiotherapy planning and image-guided biopsy, and companies such as Siemens Healthineers, through its Varian acquisition, and Elekta serve this area. Neurology and neurosurgery rely on perfusion imaging for stroke, tractography, functional MR and navigation. Orthopaedics and craniofacial surgery use 3D models, templating and implant planning, increasingly with patient-specific guides. Vascular, thoracic, abdominal and urology applications complete the field. Through 2031, cardiology and oncology are expected to remain the largest users, while surgical planning and personalised implants grow faster.


Cloud and web-based deployment is the fastest-growing mode because it avoids workstation costs and supports remote access, while on-premises server and workstation installations remain the largest base in hospitals with established infrastructure and large studies. On-premises advanced visualization uses dedicated servers and thin or thick clients inside the hospital network, with performance for large datasets and tight control of data, and it is typically sold by scanner makers and specialist vendors with perpetual licences. Cloud and web-based deployment hosts the processing in vendor or public cloud environments, so users open a browser to view and manipulate studies, and charges are by subscription or case. Hybrid models cache studies locally while sending compute-intensive tasks to the cloud. Embedded visualization in modality consoles and in intraoperative systems remains important for technologists and surgeons. Vendors are packaging AI apps in marketplaces, allowing hospitals to add features without new hardware. Through 2031, cloud delivery is expected to take a greater share of new installations, although some hospitals will keep local servers for security and speed.


Hospitals lead as end users because they own the scanners, employ the specialists and run the procedures that use advanced tools, while diagnostic imaging centres, academic centres and ambulatory surgery centres are growing groups with different needs. Large hospitals, particularly academic and tertiary centres, are the main buyers of advanced visualization and planning tools, deploying them in radiology, cardiology, surgery and radiation oncology, and often integrating with the PACS and electronic health record. Independent imaging centres use advanced tools to offer specialised exams such as cardiac CT and prostate MR, and look for efficient licensing and cloud access. Academic and research institutions use advanced visualization for trials, teaching and algorithm development, and often work with vendors on new features. Ambulatory surgery centres and specialist clinics, especially in orthopaedics and cardiology, adopt planning tools linked to implants. Medical device companies, pharmaceutical companies running imaging trials and contract research organisations are additional users. Through 2031, networked services and managed service contracts are expected to widen access for smaller providers.


The United States is the largest market, with GE HealthCare, Philips, Siemens Healthineers, Canon Medical Informatics, Fujifilm and specialist vendors supplying hospitals, and a wide ecosystem of AI companies seeking Food and Drug Administration clearance, including HeartFlow, which listed on the Nasdaq in August 2025. Reimbursement is a critical factor, with a Category I code for CT-derived fractional flow reserve since January 2024 and continued work on coverage for plaque analysis. GE HealthCare became an independent listed company in January 2023, and Siemens Healthineers completed its Varian acquisition in April 2021, strengthening radiotherapy planning. Large academic centres run 3D printing and mixed reality programmes, and health systems are adopting cloud AI platforms. Canada's provincial systems and Mexico's growing private hospital sector add demand, with budget constraints shaping purchases.

Europe has a large installed base of scanners and a strong industrial presence in imaging, with Siemens Healthineers, Philips, Sectra, Brainlab, Materialise and Agfa among the leading suppliers. The EU Medical Device Regulation, in force since May 2021, raised the bar for software documentation and clinical evidence, and the new AI Act adds obligations for high-risk systems. National health systems in the United Kingdom, Germany, France and the Nordic countries buy through tenders, and the Hospital Future Act in Germany has funded digital upgrades. Belgium is a hub for 3D printing and planning software, and Sweden and Norway are leaders in enterprise imaging. Reimbursement for advanced analysis is uneven across countries, and many hospitals depend on vendor bundles with new scanners, which keeps scanner makers influential.

Asia-Pacific is the fastest-growing region, with large investment in hospitals, scanners and AI. China has a strong domestic industry, including United Imaging, Neusoft and AI firms such as Infervision and Deepwise, with government policies supporting domestic equipment and hospital digitalisation. Japan combines advanced imaging and strong domestic suppliers such as Canon Medical, Fujifilm and Ziosoft, and an ageing population increases demand for cardiovascular and cancer imaging. India is expanding through private hospital chains and teleradiology, with growing interest in AI tools for chest and cancer imaging. South Korea has active medical AI firms and early adoption of 3D and virtual reality in surgery, and Australia has strong visualization software firms and large hospital deals. Southeast Asia, especially Singapore, Thailand and Malaysia, is investing in specialist centres.

Latin America has growing demand in private hospitals and diagnostic chains, with Brazil and Mexico leading. Hospitals in São Paulo, Mexico City and Buenos Aires adopt advanced visualization tied to new scanners, and teleradiology groups use cloud tools to serve distant regions. Public systems face budget limits and rely on tenders, with equipment bundled by multinational vendors and local distributors. Brazil's private hospital groups, such as Hospital Israelita Albert Einstein and Rede D'Or, are active in AI, 3D printing and surgical planning. Currency volatility, import costs and shortages of trained staff slow adoption, but demand for cardiac, oncology and orthopaedic services supports growth. Through 2031, subscription and cloud models that reduce upfront cost are expected to expand access.

The Gulf has the most advanced market in the region, with tertiary hospitals and specialist centres in Saudi Arabia, the United Arab Emirates and Qatar investing in advanced imaging, surgical planning and AI as part of national health strategies. Institutions such as King Faisal Specialist Hospital and Cleveland Clinic Abu Dhabi use 3D printing and navigation, and partnerships with global vendors support training and deployment. Israel has a strong ecosystem of imaging and surgical technology start-ups. In Africa, South Africa has a mature private hospital sector, while other countries rely on donor-supported centres and teleradiology, with advanced visualization limited by equipment and skills shortages. Government health programmes and investments in specialist hospitals are expected to expand adoption through 2031.

August 2025: HeartFlow completes initial public offering: The AI-based coronary analysis company listed on the Nasdaq, showing investor interest in reimbursed, cloud-delivered cardiovascular imaging analysis.

October 2024: Microsoft ends HoloLens 2 production: The decision removed a leading mixed-reality headset used in surgical planning and navigation projects and pushed developers to adapt applications to other devices.

February 2024: Apple Vision Pro begins shipping: The spatial computing headset launched in the United States and attracted healthcare developers building 3D imaging viewers and surgical planning applications.

January 2024: Category I CPT code for CT-derived fractional flow reserve takes effect: The code gave a permanent billing pathway for non-invasive coronary physiology analysis, supporting hospital adoption of AI-based cardiac CT tools.

January 2023: GE HealthCare becomes an independent listed company: The spin-off from General Electric created a pure-play imaging and diagnostics company with its own investment priorities for software, AI and advanced visualization.


Considered in this report
• Historic Year: 2020
• Base Year: 2025
• Estimated Year: 2026
• Forecast Year: 2031

Aspects covered in this report
• Global Advanced Visualization Market with its segments and regional outlook
• Various drivers and challenges
• Ongoing trends and developments
• Key developments and regulatory milestones

By Modality
• Computed Tomography
• Magnetic Resonance Imaging
• Ultrasound
• PET and SPECT
• X-Ray, Angiography and Others

By Application
• Cardiology
• Oncology
• Neurology
• Orthopaedics and Surgical Planning
• Vascular and Others

By Deployment Mode
• On-Premises
• Cloud-Based and Web-Based
• Hybrid

By End User
• Hospitals
• Diagnostic Imaging Centres
• Academic and Research Institutions
• Ambulatory Surgery Centres and Clinics